A comprehensive evaluation of apixaban in the treatment of venous thromboembolism
@article{Koehl2020ACE, title={A comprehensive evaluation of apixaban in the treatment of venous thromboembolism}, author={Jennifer Koehl and B. Hayes and H. Al-Samkari and R. Rosovsky}, journal={Expert Review of Hematology}, year={2020}, volume={13}, pages={155 - 173} }
ABSTRACT Introduction: The emergence of the direct oral anticoagulants (DOACs) offers patients more convenient and accessible alternatives to warfarin or parenteral agents for the treatment of venous thromboembolism (VTE). Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is approved for the acute treatment of deep-vein thrombosis (DVT) and pulmonary embolism (PE) as well as for the reduction in the risk of recurrent DVT and PE following initial therapy. Areas covered: This… CONTINUE READING
Topics from this paper
References
SHOWING 1-10 OF 118 REFERENCES
New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
- Medicine
- VASA. Zeitschrift fur Gefasskrankheiten
- 2014
- 32
- PDF
Oral apixaban for the treatment of acute venous thromboembolism.
- Medicine
- The New England journal of medicine
- 2013
- 1,526
- PDF
Apixaban for extended treatment of venous thromboembolism.
- Medicine
- The New England journal of medicine
- 2013
- 923
- PDF
Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial.
- Medicine
- Thrombosis and haemostasis
- 2017
- 98
Direct oral anticoagulants in hypercoagulable states
- Medicine
- Journal of Thrombosis and Thrombolysis
- 2016
- 21
Direct‐acting oral anticoagulants: pharmacology, indications, management, and future perspectives
- Medicine
- European journal of haematology
- 2015
- 55
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2008
- 240
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
- Medicine
- The New England journal of medicine
- 2012
- 1,574
- PDF
Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.
- Medicine
- Chest
- 2015
- 218
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
- Medicine
- Therapeutics and clinical risk management
- 2015
- 192
- PDF